Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer

First-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), including gefitinib and erlotinib, have proven to be highly effective agents for advanced non-small cell lung cancer (NSCLC) in patients harboring an activating EGFR mutation such as the exon 19 deletion mutati...

Full description

Saved in:
Bibliographic Details
Main Authors: Asami, Kazuhiro, Atagi, Shinji
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Inc 2014
Subjects:
Topic Highlight
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4129529/
https://ncbi.nlm.nih.gov/pubmed/25302168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v5.i4.646
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items